PILMA Statement on CMS Medicare Drug Price Negotiation Program 2029 Final Rule
PILMA shares the Administration’s goal of lowering prescription drug costs for Medicarebeneficiaries and working families. However, we are disappointed in CMS’s decision tofinalize its proposal to subject certain new drug formulations to their predecessorproduct’s negotiation timeline in the latest Medicare Drug Price Negotiation Programfinal rule. As detailed in our August comment letter, we believe these […]
PILMA Statement on Proposed COINS Act Implementation
October, 23, 2026 PILMA Statement on Proposed COINS Act Implementation The Pharmaceutical Industry Labor-Management Association (PILMA) is fully committed to policies that protect U.S. national security. But Treasury’s choice to bring biotechnology under the COINS Act’s proposed regulatory framework threatens to curtail the very investments, licensing deals, and research collaborations that power American biopharma – […]
Request for Information – Health Coverage That Works For Everyone
October 2, 2026 The Honorable Ron Wyden Ranking Member, Senate Committee on Finance 219 Dirksen Senate Office Building Washington, DC 20510 Re: Request for Information – Health Coverage That Works For Everyone Dear Ranking Member Wyden and Members of the Senate Finance Committee Minority, The Pharmaceutical Industry Labor-Management Association (PILMA) welcomes the opportunity to respond […]
Landmark Discussion Draft to Fix 340B, Lower Health Costs for American Patients & Families
August 28, 2026 The Honorable Bill Cassidy, M.D. United States Senate Chair, Committee on Health, Education, Labor, and Pensions 428 Dirksen Senate Office Building Washington, DC 20510 Re: Landmark Discussion Draft to Fix 340B, Lower Health Costs for American Patients & Families Dear Chairman Cassidy, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA) – […]
Request for Information – Commonsense Policy Options to Lower Drug Prices for Patients
August 17, 2026 The Honorable Ron Wyden Ranking Member, Senate Committee on Finance 219 Dirksen Senate Office Building Washington, DC 20510 Re: Request for Information – Commonsense Policy Options to Lower Drug Prices for Patients Dear Ranking Member Wyden and Members of the Senate Finance Committee Minority, On behalf of the Pharmaceutical Industry Labor-Management Association […]
CMS-4215-P – Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
August 17, 2026 The Honorable Mehmet Oz Administrator, Centers for Medicare and Medicaid Services U.S. Department of Health and Human Services Attn: CMS-4215-P, P.O. Box 8013, Baltimore, MD 21244 Re: CMS-4215-P – Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program Dear Administrator Oz, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA) […]
Section 301 Investigation of Germany’s Pharmaceutical Pricing Policies — Docket ID USTR-2026-0463
August 9, 2026 Ambassador Jamieson GreerUnited States Trade Representative600 17th Street NWWashington, DC 20508Re: Section 301 Investigation of Germany’s Pharmaceutical Pricing Policies — DocketID USTR-2026-0463Dear Ambassador Greer,I write today to voice my support of the United States Trade Representative’s decision toinitiate a Section 301 investigation into Germany’s pharmaceutical pricing policies. I submitthese comments in my […]
PILMA Letter to HELP Committee: MAPIA
June 15, 2026 Dear Members of the Senate Committee on Health, Education, Labor and Pensions: The Pharmaceutical Industry Labor-Management Association (PILMA), a coalition uniting the biopharmaceutical industry and America’s building trades unions around a shared commitment to medical innovation and high-quality union jobs, strongly opposes the Medication Affordability and Patent Integrity Act (S. 2658). As […]
PILMA Statement on MFN Drug Pricing Reconciliation Bill Amendment
May 20, 2026 The Pharmaceutical Industry Labor-Management Association (PILMA) issued the following statement in response to the potential inclusion of a Most Favored Nation drug pricing proposal ahead of an anticipated vote on the Senate’s budget reconciliation bill. While we believe it is crucial that policymakers prioritize making healthcare more affordable for American families, importing […]
PILMA Letter on Senate HELP Drug Pricing Hearing
April 16, 2026 The Honorable Bill Cassidy, M.D. Chairman Committee on Health, Education, Labor, and Pensions United States Senate 428 Dirksen Senate Office Building Washington, DC 20510 The Honorable Bernie Sanders Ranking Member Committee on Health, Education, Labor, and Pensions United States Senate 428 Dirksen Senate Office Building Washington, DC 20510 Re: Full Committee Hearing […]